Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.2322
-0.0002 (-0.09%)
At close: Sep 12, 2025, 4:00 PM EDT
0.2311
-0.0011 (-0.47%)
After-hours: Sep 12, 2025, 7:48 PM EDT

Intensity Therapeutics Statistics

Total Valuation

INTS has a market cap or net worth of $11.39 million. The enterprise value is $9.30 million.

Market Cap11.39M
Enterprise Value 9.30M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, after market close.

Earnings Date Nov 12, 2025
Ex-Dividend Date n/a

Share Statistics

INTS has 49.06 million shares outstanding. The number of shares has increased by 13.30% in one year.

Current Share Class 49.06M
Shares Outstanding 49.06M
Shares Change (YoY) +13.30%
Shares Change (QoQ) +24.35%
Owned by Insiders (%) 7.18%
Owned by Institutions (%) 6.59%
Float 42.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.78
P/TBV Ratio 5.22
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.06.

Current Ratio 1.40
Quick Ratio 1.02
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -334.12% and return on invested capital (ROIC) is -206.15%.

Return on Equity (ROE) -334.12%
Return on Assets (ROA) -122.67%
Return on Invested Capital (ROIC) -206.15%
Return on Capital Employed (ROCE) -564.81%
Revenue Per Employee n/a
Profits Per Employee -$1.80M
Employee Count7
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -94.50% in the last 52 weeks. The beta is 3.78, so INTS's price volatility has been higher than the market average.

Beta (5Y) 3.78
52-Week Price Change -94.50%
50-Day Moving Average 0.30
200-Day Moving Average 1.30
Relative Strength Index (RSI) 32.84
Average Volume (20 Days) 4,042,616

Short Selling Information

The latest short interest is 670,859, so 1.37% of the outstanding shares have been sold short.

Short Interest 670,859
Short Previous Month 987,865
Short % of Shares Out 1.37%
Short % of Float 1.57%
Short Ratio (days to cover) 0.13

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -12.87M
Pretax Income -15.07M
Net Income -12.58M
EBITDA n/a
EBIT -12.87M
Earnings Per Share (EPS) -$0.81
Full Income Statement

Balance Sheet

The company has $2.22 million in cash and $125,000 in debt, giving a net cash position of $2.09 million or $0.04 per share.

Cash & Cash Equivalents 2.22M
Total Debt 125,000
Net Cash 2.09M
Net Cash Per Share $0.04
Equity (Book Value) 2.18M
Book Value Per Share 0.08
Working Capital 874,000
Full Balance Sheet

Cash Flow

Operating Cash Flow -11.09M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

INTS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -13.30%
Shareholder Yield -13.30%
Earnings Yield -110.42%
FCF Yield n/a

Analyst Forecast

The average price target for INTS is $4.50, which is 1,837.98% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.50
Price Target Difference 1,837.98%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1